Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 


 

(Mark One)

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Quarterly Period Ended June 30, 2004

 

OR

 

¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the Transition Period from              to             

 

Commission File Number 001-11141

 


 

HEALTH MANAGEMENT ASSOCIATES, INC.

(Exact name of Registrant as specified in its charter)

 


 

Delaware   61-0963645

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

5811 Pelican Bay Boulevard, Suite 500

Naples, Florida

  34108-2710
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (239) 598-3131

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

At August 5, 2004, 243,404,283 shares of the Registrant’s Class A Common Stock were outstanding.

 



Table of Contents

HEALTH MANAGEMENT ASSOCIATES, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2004

 

INDEX

 

     Page

PART I - FINANCIAL INFORMATION

    

Item 1.

   Financial Statements     
     Consolidated Statements of Income - Three Months Ended June 30, 2004 and 2003    3
     Consolidated Statements of Income - Nine Months Ended June 30, 2004 and 2003    4
     Condensed Consolidated Balance Sheets - June 30, 2004 and September 30, 2003    5
     Condensed Consolidated Statements of Cash Flows - Nine Months Ended June 30, 2004 and 2003    6
     Notes to Interim Condensed Consolidated Financial Statements    7

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    11

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk    25

Item 4.

   Controls and Procedures    25
PART II - OTHER INFORMATION    26

Signatures

   27

Index To Exhibits

   28

Exhibits

    

 

2


Table of Contents

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

HEALTH MANAGEMENT ASSOCIATES, INC.

CONSOLIDATED STATEMENTS OF INCOME

(in thousands, except per share amounts)

(unaudited)

 

     Three Months Ended
June 30,


     2004

   2003

Net patient service revenue

   $ 817,341    $ 647,127

Costs and expenses:

             

Salaries and benefits

     315,776      245,477

Supplies and other

     239,087      185,328

Provision for doubtful accounts

     62,514      46,448

Depreciation and amortization

     34,030      28,003

Rent expense

     16,540      12,466

Interest, net

     3,640      3,802
    

  

Total costs and expenses

     671,587      521,524
    

  

Income before minority interests and income taxes

     145,754      125,603

Minority interests in earnings of consolidated entities

     1,580      1,121
    

  

Income before income taxes

     144,174      124,482

Provision for income taxes

     54,891      48,561
    

  

Net income

   $ 89,283    $ 75,921
    

  

Net income per share:

             

Basic

   $ .37    $ .32
    

  

Diluted

   $ .36    $ .30
    

  

Dividends per share

   $ .02    $ .02
    

  

Weighted average number of shares outstanding:

             

Basic

     243,175      239,108
    

  

Diluted

     247,136      257,379
    

  

 

See accompanying notes.

 

3


Table of Contents

HEALTH MANAGEMENT ASSOCIATES, INC.

CONSOLIDATED STATEMENTS OF INCOME

(in thousands, except per share amounts)

(unaudited)

 

    

Nine Months Ended

June 30,


     2004

   2003

Net patient service revenue

   $ 2,407,801    $ 1,903,018

Costs and expenses:

             

Salaries and benefits

     943,922      733,934

Supplies and other

     711,395      548,796

Provision for doubtful accounts

     180,179      137,772

Depreciation and amortization

     99,413      81,203

Rent expense

     49,386      36,677

Interest, net

     12,802      11,275
    

  

Total costs and expenses

     1,997,097      1,549,657
    

  

Income before minority interests and income taxes

     410,704      353,361

Minority interests in earnings of consolidated entities

     4,115      3,106
    

  

Income before income taxes

     406,589      350,255

Provision for income taxes

     155,520      136,613
    

  

Net income

   $ 251,069    $ 213,642
    

  

Net income per share:

             

Basic

   $ 1.04    $ .89
    

  

Diluted

   $ 1.02    $ .85
    

  

Dividends per share

   $ .06    $ .06
    

  

Weighted average number of shares outstanding:

             

Basic

     242,488      238,790
    

  

Diluted

     246,901      257,186
    

  

 

See accompanying notes.

 

4


Table of Contents

HEALTH MANAGEMENT ASSOCIATES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

    

June 30,

2004


    September 30,
2003


 
     (Unaudited)        
ASSETS                 

Current assets:

                

Cash and cash equivalents

   $ 115,612     $ 395,338  

Accounts receivable, net

     632,314       527,254  

Supplies, prepaid expenses and other assets

     107,147       123,247  

Funds held by trustee

     12,541       17,470  

Deferred income taxes

     30,027       30,027  
    


 


Total current assets

     897,641       1,093,336  

Property, plant and equipment

     2,354,888       1,983,151  

Less: accumulated depreciation and amortization

     (651,426 )     (555,436 )
    


 


Net property, plant and equipment

     1,703,462       1,427,715  

Funds held by trustee

     52,160       15,924  

Excess of cost over acquired net assets, net

     722,572       397,825  

Deferred charges and other assets

     43,837       44,687  
    


 


Total assets

   $ 3,419,672     $ 2,979,487  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY                 

Current liabilities:

                

Accounts payable

     145,401     $ 136,136  

Accrued expenses and other liabilities

     137,050       121,980  

Income taxes - currently payable

     11,028       5,400  

Current maturities of long-term debt

     8,790       9,447  
    


 


Total current liabilities

     302,269       272,963  

Deferred income taxes

     48,984       48,984  

Other long-term liabilities

     87,491       58,402  

Long-term debt

     1,024,150       924,713  

Minority interests in consolidated entities

     41,352       37,350  

Stockholders’ equity:

                

Preferred stock, $.01 par value, 5,000 shares authorized

     —         —    

Common stock, Class A, $.01 par value, 750,000 shares authorized, 265,881 and 262,705 shares issued at June 30, 2004 and September 30, 2003, respectively

     2,659       2,627  

Additional paid-in capital

     442,012       399,782  

Retained earnings

     1,771,411       1,535,322  
    


 


       2,216,082       1,937,731  

Less: treasury stock, 22,500 shares of common stock, at cost, at both June 30, 2004 and September 30, 2003

     (300,656 )     (300,656 )
    


 


Total stockholders’ equity

     1,915,426       1,637,075  
    


 


Total liabilities and stockholders’ equity

   $ 3,419,672     $ 2,979,487  
    


 


 

See accompanying notes.

 

5


Table of Contents

HEALTH MANAGEMENT ASSOCIATES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

 

    

Nine Months Ended

June 30,


 
     2004

    2003

 

Cash flows from operating activities:

                

Net income

   $ 251,069     $ 213,642  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Depreciation and amortization

     99,413       81,203  

Provision for doubtful accounts

     180,179       137,772  

Gain on sale of fixed assets

     (2,669 )     (363 )

Changes in assets and liabilities:

                

Accounts receivable

     (286,099 )     (163,986 )

Supplies and other current assets

     25,124       (9,299 )

Deferred charges and other assets

     (4,830 )     1,512  

Accounts payable

     5,390       (4,221 )

Accrued expenses and other liabilities

     6,481       10,398  

Income taxes - currently payable

     21,628       (362 )

Other long term liabilities

     33,091       (575 )
    


 


Net cash provided by operating activities

     328,777       265,721  
    


 


Cash flows from investing activities:

                

Acquisition of facilities, net of cash acquired and purchase price adjustments

     (517,774 )     (19,269 )

Additions to property, plant and equipment

     (173,569 )     (123,321 )

Proceeds from sale of property, plant and equipment

     4,509       774  

(Increase) decrease in funds held by trustee

     (31,308 )     15  
    


 


Net cash used in investing activities

     (718,142 )     (141,801 )
    


 


Cash flows from financing activities:

                

Proceeds from borrowings, net of issuance costs

     283,947       9,782  

Principal payments on debt

     (185,748 )     (6,969 )

Payment of dividends

     (14,822 )     (14,608 )

Proceeds from issuance of common stock

     26,262       12,413  
    


 


Net cash provided by financing activities

     109,639       618  
    


 


Net (decrease) increase in cash and cash equivalents

     (279,726 )     124,538  

Cash and cash equivalents at beginning of period

     395,338       123,736  
    


 


Cash and cash equivalents at end of period

   $ 115,612     $ 248,274  
    


 


 

See accompanying notes.

 

6


Table of Contents

HEALTH MANAGEMENT ASSOCIATES, INC.

NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

1. Basis of Presentation

 

The condensed consolidated balance sheet as of September 30, 2003 has been derived from the audited consolidated financial statements included in our 2003 Annual Report on Form 10-K. The interim condensed consolidated financial statements at June 30, 2004, and for the three and nine month periods ended June 30, 2004 and 2003 are unaudited; however, such interim statements reflect all adjustments (consisting only of a normal recurring nature) which are, in the opinion of our management, necessary for a fair presentation of our financial position and results of operations for the interim periods presented. Our results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year. The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules. The interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in our 2003 Annual Report on Form 10-K.

 

The interim condensed consolidated financial statements include all assets, liabilities, revenues and expenses of certain entities which are controlled by us but not wholly-owned. Accordingly, we have recorded minority interests in the earnings and equity of such entities to reflect the ownership interests of such minority shareholders in the respective entities.

 

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires our management to make estimates and assumptions that affect the amounts reported in the interim condensed consolidated financial statements. Our actual results could differ from these estimates.

 

2. Stock Compensation

 

We have elected to follow Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees (“APB 25”). Under APB 25, because the exercise price of employee stock options equals the market price of the underlying stock on the date of grant, no compensation expense is recognized. As a result, pro forma disclosure of alternative fair value accounting is required under Financial Accounting Standards Board (“FASB”) Statement of Financial Accounting Standards (“SFAS”) No. 123, Accounting for Stock-Based Compensation, utilizing an option valuation model.

 

7


Table of Contents

HEALTH MANAGEMENT ASSOCIATES, INC.